One month's cost of pirfenidone/asri

Pirfenidone/Pirfenidone is an oral drug used to treat idiopathic pulmonary fibrosis (IPF). It mainly improves the quality of life of patients by slowing down the progression of pulmonary fibrosis. The recommended daily maintenance dose of pirfenidone is 801 mg three times daily, for a total of 2403 mg/day. At the beginning of treatment, patients need to be gradually titrated to this full dose over 14 days.

The specific dosage adjustment plan is as follows: from the 1st to the 7th day of treatment, the patient should take 267mg three times a day, a total of 801mg; from the 8th to the 14th day, the dose is adjusted to 534mg three times a day, a total of 1602mg; starting from the 15th day, the patient will maintain 801mg three times a day until the end of treatment. It is important to note that this drug should be taken with food to increase its bioavailability.

In China, the original drug of pirfenidone has been approved for marketing and included in Class B medical insurance. This means that patients who meet the indications can enjoy a certain percentage of drug cost reimbursement. However, the specific situation of reimbursement depends on whether the patient meets the relevant criteria of medical insurance. According to market research, a box of pirfenidone containing 100 mg*54 pills currently sells for about 500 yuan.

In addition to the original drug, generic drugs of pirfenidone are also available in overseas markets such as India. These generic drugs are usually more affordable. A box of 200mg*30 tablets on the market costs about one hundred yuan. It should be noted that the ingredients of generic drugs are basically the same as the original drugs, but prices may fluctuate due to market and exchange rate changes.

The monthly cost of pirfenidone varies mainly based on the patient's medication regimen and the type of drug selected (original drug or generic drug). If calculated based on the daily maintenance dose of 2403 mg, the monthly cost is approximately one thousand yuan. Therefore, when patients choose drugs, they need to comprehensively consider factors such as drug effectiveness, price, and medical insurance reimbursement policies.